PortfoliosLab logo

Artelo Biosciences, Inc. (ARTL)

Equity · Currency in USD · Last updated Mar 27, 2023

Share Price Chart


Loading data...

Performance

The chart shows the growth of $10,000 invested in Artelo Biosciences, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $348 for a total return of roughly -96.52%. All prices are adjusted for splits and dividends.


-100.00%-50.00%0.00%50.00%NovemberDecember2023FebruaryMarch
-96.52%
41.35%
ARTL (Artelo Biosciences, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ARTL

Artelo Biosciences, Inc.

Return

Artelo Biosciences, Inc. had a return of -27.68% year-to-date (YTD) and -68.01% in the last 12 months. Over the past 10 years, Artelo Biosciences, Inc. had an annualized return of -54.85%, while the S&P 500 had an annualized return of 8.54%, indicating that Artelo Biosciences, Inc. did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month-31.48%-0.66%
Year-To-Date-27.68%3.42%
6 months-39.60%5.67%
1 year-68.01%-10.89%
5 years (annualized)-62.35%8.93%
10 years (annualized)-54.85%8.54%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202311.42%-11.02%
2022-10.39%-16.81%-14.29%17.48%

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Artelo Biosciences, Inc. Sharpe ratio is -0.78. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.80-0.60-0.40-0.20NovemberDecember2023FebruaryMarch
-0.78
-0.47
ARTL (Artelo Biosciences, Inc.)
Benchmark (^GSPC)

Dividend History


Artelo Biosciences, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%NovemberDecember2023FebruaryMarch
-99.35%
-17.21%
ARTL (Artelo Biosciences, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Artelo Biosciences, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Artelo Biosciences, Inc. is 99.35%, recorded on Mar 24, 2023. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.35%Jan 19, 20181054Mar 24, 2023
-20%Dec 11, 20172Dec 21, 20171Jan 2, 20183

Volatility Chart

Current Artelo Biosciences, Inc. volatility is 56.26%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%NovemberDecember2023FebruaryMarch
56.26%
19.50%
ARTL (Artelo Biosciences, Inc.)
Benchmark (^GSPC)